114 related articles for article (PubMed ID: 21776848)
1. [Lymphatic targeting study of pingyangmycin-activated carbon nanoparticles treating oral cancer lymph node metastasis].
Sun ML; Xie WH; Wang CM; Wen YM
Hua Xi Kou Qiang Yi Xue Za Zhi; 2011 Jun; 29(3):253-6, 263. PubMed ID: 21776848
[TBL] [Abstract][Full Text] [Related]
2. [Preparation of lymphatic targeting dosage form: pingyangmycin absorbed on activated carbon nanoparticles].
Sun ML; Wen YM; Wang CM; Li LJ; Wang XY
Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Jun; 22(3):183-5. PubMed ID: 15293458
[TBL] [Abstract][Full Text] [Related]
3. [Anticancer effects of Pingyangmycin-activated carbon nanoparticles against human oral squamous carcinoma Tca8113 and BcaCD885 cell lines in vitro].
Sun ML; Wang CM; Wen YM
Hua Xi Kou Qiang Yi Xue Za Zhi; 2010 Jun; 28(3):257-60. PubMed ID: 20635652
[TBL] [Abstract][Full Text] [Related]
4. [The study of cucurbitacin BE polylactic acid nanoparticles delivering cucurbitacin BE to metastasized cervical lymph nodes in mice with oral cancer].
Yang K; Wen Y; Wang C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Dec; 21(6):477-80. PubMed ID: 14732987
[TBL] [Abstract][Full Text] [Related]
5. [Clinical application of anticancer nanoparticles targeting metastasis foci of cervical lymph nodes in patients with oral carcinoma].
Yang K; Wen Y; Wang C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Dec; 21(6):447-50. PubMed ID: 14732978
[TBL] [Abstract][Full Text] [Related]
6. Uptake of bleomycin adsorbed on to activated carbon particles by regional lymph nodes of the esophagus in dogs.
Shimada M; Aikou T; Natsugoe S; Shimazu H; Nakamura K
Anticancer Drug Des; 1993 Aug; 8(4):249-55. PubMed ID: 7694587
[TBL] [Abstract][Full Text] [Related]
7. [Effect of the conjugate composed of a human monoclonal antibody and pingyangmycin on mammary cancer].
Wang WG; Wang SH; Xue YC; Zhen YS
Yao Xue Xue Bao; 1995; 30(8):583-7. PubMed ID: 8571778
[TBL] [Abstract][Full Text] [Related]
8. Chemocoagulation of metastatic lymph nodes using a suspension of mitomycin C-adsorbing activated carbon particles in 80% ethanol.
Seiki K; Takahashi T; Sawai K; Okano S; Hagiwara A
Cancer Invest; 1993; 11(4):379-87. PubMed ID: 8324642
[TBL] [Abstract][Full Text] [Related]
9. [Combined injection of pingyangmycin & dexamethasone for the treatment of maxillofacial and cervical venous malformations].
Zhai J; Zhai XD
Zhonghua Zheng Xing Wai Ke Za Zhi; 2012 May; 28(3):168-71. PubMed ID: 22870701
[TBL] [Abstract][Full Text] [Related]
10. Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice.
Gong JH; Liu XJ; Li Y; Zhen YS
Cancer Chemother Pharmacol; 2012 May; 69(5):1323-32. PubMed ID: 22311160
[TBL] [Abstract][Full Text] [Related]
11. Lymph node mapping with carbon nanoparticles and the risk factors of lymph node metastasis in gastric cancer.
Wang H; Chen MM; Zhu GS; Ma MG; Du HS; Long YP
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):865-870. PubMed ID: 27924502
[TBL] [Abstract][Full Text] [Related]
12. [Antitumor effect of the novel immunoconjugate composed of pingyangmycin and anti-type IV collagenase monoclonal antibody].
Dai Y; Liu XJ; Zhen YS
Yao Xue Xue Bao; 2006 Jan; 41(1):41-6. PubMed ID: 16683526
[TBL] [Abstract][Full Text] [Related]
13. [Effects of Pingyangmycin albumin microspheres on sclerostenosis of the rabbit central auricular arteries].
Gao QH; Zheng GJ; Wang XY; Zhou L; Dong JZ; Wang CM; Wen YM
Shanghai Kou Qiang Yi Xue; 2005 Feb; 14(1):42-7. PubMed ID: 15747013
[TBL] [Abstract][Full Text] [Related]
14. A clinical study of pingyangmycin sclerotherapy for venous malformation: an evaluation of 281 consecutive patients.
Bai N; Chen YZ; Fu YJ; Wu P; Zhang WN
J Clin Pharm Ther; 2014 Oct; 39(5):521-6. PubMed ID: 24924412
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate bound to carbon particles used for treating cancers with lymph node metastases in animal experiments and a clinical pilot study.
Hagiwara A; Takahashi T; Sawai K; Sakakura C; Hoshima M; Ohyama T; Ohgaki M; Imanishi T; Yamamoto A; Muranishi S
Cancer; 1996 Nov; 78(10):2199-209. PubMed ID: 8918415
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study of interstitial chemotherapy with PYM delivered from a solid implantable biodegradable polymer against human tongue SCC in tumor-bearing nude mice].
Chen CJ; Zhang ZY
Shanghai Kou Qiang Yi Xue; 2005 Oct; 14(5):519-24. PubMed ID: 16288335
[TBL] [Abstract][Full Text] [Related]
17. Enhanced anti-cancer efficacy on lymph node metastasis using peplomycin adsorbed on small activated carbon particles.
Ito M; Hagiwara A; Iwamoto A; Shimotsuma M; Yoneyama C; Sasabe T; Takahashi T
Anticancer Drug Des; 1991 Jul; 6(3):169-77. PubMed ID: 1714736
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of the growth of hepatoma and hepatic metastasis by pingyangmycin conjugated with Fab' fragment of monoclonal antibody].
Liu X; Shang B; Liu X
Zhonghua Yi Xue Za Zhi; 2001 Feb; 81(4):201-4. PubMed ID: 11798873
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the tracing effect of carbon nanoparticle and carbon nanoparticle-epirubicin suspension in axillary lymph node dissection for breast cancer treatment.
Du J; Zhang Y; Ming J; Liu J; Zhong L; Liang Q; Fan L; Jiang J
World J Surg Oncol; 2016 Jun; 14(1):164. PubMed ID: 27335011
[TBL] [Abstract][Full Text] [Related]
20. Enhanced therapeutic efficacy of intralymph-nodal etoposide on distal lymph node metastases using a new dosage format--activated carbon particles adsorbing etoposide.
Hagiwara A; Takahashi T; Sawai K; Seiki K; Ito M; Okano S; Sakakura C; Shobayashi S; Muranishi S; Tomoda H
Anticancer Drug Des; 1992 Apr; 7(2):163-8. PubMed ID: 1575889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
